ClinicalTrials.Veeva

Menu

Prescribing Appropriateness of Thrombo-prophylaxis in Intensive Care Unit of Tertiary Hospital

A

Ain Shams University

Status

Completed

Conditions

DVT

Treatments

Other: DVT prophyllaxis

Study type

Observational

Funder types

Other

Identifiers

NCT06539156
2887764466

Details and patient eligibility

About

Hospitalized patients are at high risk of venous thromboembolism (VTE), and the appropriate use of thromboprophylaxis can significantly reduce the incidence of VTE in high-risk patients. We investigated the pattern of VTE prophylaxis administration among elderly medical patients and assessed its appropriateness based on the American College of Chest Physicians (ACCP) recommendations. Methods A cross-sectional single-center study will be conducted between July 2024 and December 2024, including hospitalized (> 48 h), (≥ 60 years), medical and surgical patients, and excluding patients receiving anticoagulant for other reason, having contraindication to thromboprophylaxis, or had VTE diagnosed within 48 h. The Padua and caprine prediction scores will be used to determine the patients' risk for VTE, and thromboprophylaxis use will be assessed against the ACCP recommendations.

Enrollment

400 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient records

  • admitted to the ICU with
  • medical or surgical causes
  • recieved anticoagulants for DVT prophylaxis

Exclusion criteria

  • Patients already on anticoagulant therapy,
  • had history of previous DVT,
  • had End-stage liver disease,
  • admitted with hemorrhage/bleeding
  • not prescribed DVT prophylaxis

Trial design

400 participants in 2 patient groups

Medical Patients
Treatment:
Other: DVT prophyllaxis
Surgical Patients
Treatment:
Other: DVT prophyllaxis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems